宝宝发烧怎么办?

正冬春之交,气温变化大,流感病毒汹涌,而小孩子由于自身发育不全,抵抗力弱,容易因为感冒或者其他原因发烧。今天在药物咨询门诊,一位年轻的妈妈过来对我说,她是个二孩妈妈,她现在非常怕孩子生病,特别是二个孩子同时生病,如果遇到这样的情况,她常常顾此失彼。而最近不少孩子感冒发烧的现象比较多,她想了解一下面对孩子发烧怎么处理。     

小孩生病时使用抗生素须知

正生活中家里小孩最开始感冒发烧生病时,大部分妈妈怕去医院看病,因为医院人多嘈杂,挂号排队麻烦,更容易引起交叉感染,首先都会选择自行在家买些感冒药、消炎药比如阿莫西林等给孩子喂药。那么抗生素到底能不能随便给小孩用呢?我们一起来了解下。孩子有炎症要看情况使用抗生素孩子生病发热时,无论是喉咙发炎,还是支气管炎、肺炎等,人们通常会说孩子有炎症了。但医师在给孩子看病时,会根据化验及检     

提高孩子免疫力

一些孩子好像一年到头都在感冒、发烧，每个月要看好几次医生，父母不免忧心忡忡：“我的孩子经常生病，是不是抵抗力太差了?”     

孩儿发烧38.5℃并非是绝对分界线(一)

正近段时间气温骤降,有许多孩子因受凉而感冒发烧。不少家长都很纠结,孩子夜里发烧,到底要不要叫醒孩子喂退烧药?有些孩子一喂药就呕吐,家长又该不该坚持喂?究竟应该怎么护理发烧的孩子,成为许多家长最关心的难题。笔者就此采访了相关的儿科专家。1.退烧药只能缓解症状近几日,4岁的子涵出现流鼻涕,发烧。子涵妈妈给他量体温发现有     

微健康

亲子 北京儿蘸医院 北京儿童医院官方微博 孩子感冒和大人感冒症状基本上相似,主要表现为流鼻涕、打喷嚏、咳嗽、发烧、浑身酸痛、不爱吃饭。小儿感冒和成人感冒的不同：一是孩子感冒后,全身症状会比大人重,出现发烧     

人血白蛋白不能当补药

正7岁的琪琪,上小学二年级。她浓眉大眼、玲珑可爱,平时听话文静,学习成绩优秀,家长、邻居和老师都喜欢她。但美中不足的是,生来体质瘦弱。天气变化时候,稍有不慎就会感冒,每次感冒后需要十来天、还得打几日吊瓶才能恢复。妈妈看在眼里,痛在心上,却又无奈。后来听同事说人血白蛋白能增强孩子免疫力,有很好预防感冒等疾病的作用,于是妈妈特地请假带琪琪到医院儿科要求医师给打人血白蛋白。但接诊医师并没有采纳妈     

宝宝用药的对与错

家长对孩子患上的一些小疾病可能会使用一些家庭常备药,但是不当服用会增加药品不良反应风险,甚至会引起生命危险,专家提醒乱用药会让孩子更"受伤"。用药不要苛求"见效快"在很多家庭中,孩子一旦生病,家长便急得不得了,恨不得孩子的病立即好转。目前不少家长有这样一个认识误区,就是孩子一旦感冒、发烧,输液治疗     

神苗知识加油站为宝宝健康加油

宝宝感冒、咳嗽、发烧……妈妈们心急如焚,不知道应该如何用药,这期培训课堂主要讲述普通感冒及流感的症状区别,以及感冒容易引起的并发症,并告诉妈妈们如何辩证用药,帮助宝宝们用最少的药以最快的速度把感冒及并发症赶跑!     

给宝宝洗澡,您做好准备了吗

29岁的晓兰刚当上妈妈,欣喜之余却遭遇她意想不到的尴尬──不知道怎么为宝宝洗澡.近段时间天气变化不定,时冷时热,她非常担心把孩子弄感冒了.     

懒得出奇也是病

随着医疗条件的改善，静脉输液成了人们生病后(例如感冒发烧、腹痛、腹泻等)寻求康复的治疗方法之一。     

Oestrogen and the cardiovascular system: the good, the bad and the puzzling

The concept that oestrogen replacement therapy is cardioprotective has been challenged recently by the negative results of randomized clinical trials in coronary heart disease. These data have come at a time of rapid advances in our understanding of the cellular mechanisms of oestrogen. In particular, the cloning of the classical oestrogen receptor (ERalpha), the identification of a novel ER isoform (ERbeta), the availability of specific ERalpha and ERbeta knockout mice models, and the elucidation of receptor functions and signalling pathways linked to non-genomic actions of oestrogen are helping to unravel this complex biology. In this article, these advances will be discussed with particular emphasis on the regulation of nitric oxide synthesis by oestrogen. Furthermore, the puzzling issues that have emerged and the potential for development of novel and specific therapeutic approaches will be highlighted.     

Ketamine and phencyclidine: the good,the bad and the unexpected

The history of ketamine and phencyclidine from their development as potential clinical anaesthetics through drugs of abuse and animal models of schizophrenia to potential rapidly acting antidepressants is reviewed. The discovery in 1983 of the NMDA receptor antagonist property of ketamine and phencyclidine was a key step to understanding their pharmacology, including their psychotomimetic effects in man. This review describes the historical context and the course of that discovery and its expansion into other hallucinatory drugs. The relevance of these findings to modern hypotheses of schizophrenia and the implications for drug discovery are reviewed. The findings of the rapidly acting antidepressant effects of ketamine in man are discussed in relation to other glutamatergic mechanisms.Tables of Links

医院以及医院药学的定位和服务方式转变

本文以新一轮医药卫生体制改革的内容为切入点,分析我国现有医院与医院药学的现状,并与国外医疗体系做对比;提出了公立医院的定位问题及如何发挥医院药学在医院中的作用,转变服务方式,加强药师队伍建设等问题。     

Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising

Hydrogen sulfide is rapidly gaining ground as a physiological mediator of inflammation, but there is no clear consensus as to its precise role in inflammatory signaling. This article discusses the disparate anti-inflammatory ('the good') and proinflammatory ('the bad') effects of endogenous and pharmacological H(2)S in disparate animal model and cell culture systems. We also discuss 'the ugly', such as problems of using wholly specific inhibitors of enzymatic H(2)S synthesis, and the use of pharmacological donor compounds, which release H(2)S too quickly to be physiologically representative of endogenous H(2)S synthesis. Furthermore, recently developed slow-release H(2)S donors, which offer a more physiological approach to understanding the complex role of H(2)S in acute and chronic inflammation ('the promising') are discussed.     

Balancing the risks and the benefits

Pharmaceutical research organizations can benefit from outsourcing discovery activities that are not core competencies of the organization. The core competencies for a discovery operation are the expertise and systems that give the organization an advantage over its competition. Successful outsourcing ventures result in cost reduction, increased operation efficiency and optimization of resource allocation. While there are pitfalls to outsourcing, including poor partner selection and inadequate implementation, outsourcing can be a powerful tool for enhancing drug discovery operations.